Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ASPIRE: Adult SPasticity International REgistry on BOTOX Treatment

Next Previous
X
Search
Trial Profile

ASPIRE: Adult SPasticity International REgistry on BOTOX Treatment

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity; Paresis
  • Focus Therapeutic Use
  • Acronyms ASPIRE
  • Sponsors AbbVie; Allergan

    • Most Recent Events

    • 27 Apr 2023 Subgroup post hoc analysis results presented at the 75th Annual Meeting of the American Academy of Neurology 2023.
    • 18 Sep 2022 Results of subset of patients who are naive to botulinum toxins for spasticity presented at the 26th International Congress of Parkinson's Disease and Movement Disorders
    • 18 Sep 2022 Results of sub-group post-hoc analysis assessing treatment utilization for pronated forearm and intrinsic plus hand postures in patients with upper limb spasticity presented at the 26th International Congress of Parkinson's Disease and Movement Disorders

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top